相似文献
1
Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
J Drug Assess. 2013 May 7;2(1):67-71. doi: 10.3109/21556660.2013.801605. eCollection 2013.
2
Cross-sectional survey evaluating blood pressure control ACHIEVEment in hypertensive patients treated with multiple anti-hypertensive agents in Belgium and Luxembourg.
PLoS One. 2018 Nov 1;13(11):e0206510. doi: 10.1371/journal.pone.0206510. eCollection 2018.
3
Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin.
Curr Med Res Opin. 2015 May;31(5):901-11. doi: 10.1185/03007995.2015.1027185.
4
A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Curr Med Res Opin. 2014 Dec;30(12):2415-22. doi: 10.1185/03007995.2014.964853. Epub 2014 Sep 29.
5
6
Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Kardiol Pol. 2017;75(12):1357-1367. doi: 10.5603/KP.2017.0237.
7
Antihypertensive combination therapy in primary care offices: results of a cross-sectional survey in Switzerland.
Int J Gen Med. 2014 Dec 9;7:549-56. doi: 10.2147/IJGM.S74023. eCollection 2014.
8
A single-pill combination of amlodipine besylate and atorvastatin calcium.
Drugs Today (Barc). 2006 Mar;42(3):157-75. doi: 10.1358/dot.2006.42.3.953593.
9
Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
J Gen Intern Med. 2017 Jun;32(6):619-625. doi: 10.1007/s11606-016-3972-z. Epub 2017 Jan 3.
10
Comparison of dual antiplatelet therapy prescribed as one-pill versus two-pill regimen. A pooled analysis of individual patient data from the three MR-CAPCIS trials.
Thromb Haemost. 2016 Jul 4;116(1):78-86. doi: 10.1160/TH15-12-0931. Epub 2016 Mar 31.
引用本文的文献
1
The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials.
Cureus. 2023 Oct 14;15(10):e47032. doi: 10.7759/cureus.47032. eCollection 2023 Oct.
2
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
High Blood Press Cardiovasc Prev. 2019 Oct;26(5):399-404. doi: 10.1007/s40292-019-00336-2. Epub 2019 Aug 28.
本文引用的文献
1
Aliskiren/amlodipine as a single-pill combination in hypertensive patients: subgroup analysis of elderly patients, with metabolic risk factors or high body mass index.
J Drug Assess. 2012 Dec 25;2(1):1-10. doi: 10.3109/21556660.2012.762367. eCollection 2013.
2
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
J Hypertens. 2013 Mar;31 Suppl 1:S13-7. doi: 10.1097/HJH.0b013e32835d2b05.
3
The evening versus morning polypill utilization study: the TEMPUS rationale and design.
Eur J Prev Cardiol. 2014 Apr;21(4):425-33. doi: 10.1177/2047487313476961. Epub 2013 Feb 4.
4
Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society.
Eur Heart J. 2013 May;34(20):1471-4. doi: 10.1093/eurheartj/ehs446. Epub 2013 Jan 25.
5
Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
J Am Soc Hypertens. 2013 Jan-Feb;7(1):46-60. doi: 10.1016/j.jash.2012.11.001.
6
A 'polypill' aimed at preventing cardiovascular disease could prove highly cost-effective for use in Latin America.
Health Aff (Millwood). 2013 Jan;32(1):155-64. doi: 10.1377/hlthaff.2011.0948.
7
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
Curr Pharm Des. 2013;19(21):3753-65. doi: 10.2174/13816128113199990299.
8
The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
PLoS One. 2012;7(12):e52145. doi: 10.1371/journal.pone.0052145. Epub 2012 Dec 19.
9
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
J Hypertens. 2013 Feb;31(2):414-21. doi: 10.1097/HJH.0b013e32835bf7b0.
10
Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
Expert Opin Pharmacother. 2012 Dec;13(18):2699-709. doi: 10.1517/14656566.2012.745511. Epub 2012 Nov 21.
Zotero 插件